The Hemodynamic Response to Prolonged Dobutamine Infusion

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01042873

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose other
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01042873
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Israel (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01042873. Allocation not applicable; no masking; primary purpose other. Start 2010-01 (registry gives no type); primary completion 2020-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Hemodynamic Response to Prolonged Dobutamine Infusion
Condition
Healthy
Condition
Heart Failure
Intervention (Drug)
3 hours intravenous dobutamine
Lead sponsor
Hadassah Medical Organization (class: other)

Record details

Record id
cardio:ct-nct01042873
Content hash
59085db6059e447b2ed8a4b709d8fa48b746cf448ca73549ec5210654d88feb3